Summit Global Investments - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 73 filers reported holding IRADIMED CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$257
-6.9%
5,7880.0%0.02%
-5.6%
Q2 2023$276
-6.4%
5,788
-22.8%
0.02%
-21.7%
Q1 2023$295
-99.9%
7,500
-31.8%
0.02%
-17.9%
Q3 2021$369,000
+25.1%
11,000
-20.3%
0.03%
-6.7%
Q3 2020$295,000
-56.3%
13,800
-52.6%
0.03%
-61.5%
Q2 2020$675,000
+15.4%
29,100
+6.2%
0.08%
-8.2%
Q1 2020$585,00027,4000.08%
Other shareholders
IRADIMED CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 783,066$30,814,0005.13%
Soleus Capital Management, L.P. 773,694$30,444,8593.15%
RK Capital 335,400$13,197,9902.90%
Capital Impact Advisors, LLC 19,390$762,9970.94%
Ranger Investment Management 205,692$8,093,9800.54%
Bares Capital Management 317,000$12,473,9500.44%
Hillsdale Investment Management Inc. 109,100$4,293,0850.37%
CORNERCAP INVESTMENT COUNSEL INC 37,007$1,456,2250.26%
Riverwater Partners LLC 6,234$245,3080.22%
RICE HALL JAMES & ASSOCIATES, LLC 72,271$2,843,8640.16%
View complete list of IRADIMED CORP shareholders